Yahoo
OTC Markets OTCPK - Delayed Quote USD

Carl Zeiss Meditec AG (CZMWY)

38.92 -1.31 (-3.26%)
At close: November 6 at 4:00:00 PM EST
View in AlphaSpace Currency in EUR All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
9/30/2025
9/30/2024
9/30/2023
9/30/2022
Total Revenue
2,181,245 2,227,645 2,066,127 2,089,300 1,902,836
Cost of Revenue
-1,056,648 -1,052,448 -977,497 -883,535 -775,238
Gross Profit
1,124,397 1,175,197 1,088,630 1,205,765 1,127,598
Selling, General and Administrative Expenses
-634,419 -626,519 -569,208 -504,057 -438,060
Research and Development Expenses
-335,475 -326,275 -343,089 -349,278 -291,365
Other Income/Expense, Operating
3,317 917 18,119 -4,306 -1,294
Operating Income/Expenses
-966,577 -951,877 -894,178 -857,641 -730,719
Total Operating Profit/Loss
157,820 223,320 194,452 348,124 396,879
Total Net Finance Income/Expense
-6,295 -18,995 37,852 27,131 55,240
Net Investment Income
5,567 -10,433 8,562 37,309 -48,630
Non-Operating Income/Expenses, Total
-728 -29,428 46,414 64,440 6,610
Pretax Income
156,692 193,892 240,866 412,564 403,489
Provision for Income Tax
-36,447 -51,547 -60,712 -120,555 -107,578
Net Income from Continuing Operations
120,245 142,345 180,154 292,009 295,911
Net Income after Extraordinary Items and Discontinued Operations
120,345 142,345 180,154 292,009 295,911
Non-Controlling/Minority Interests
1,165 -1,135 -1,428 -1,613 -2,002
Net Income after Non-Controlling/Minority Interests
121,510 141,210 178,726 290,396 293,909
Net Income Available to Common Stockholders
121,510 141,210 178,726 290,396 293,909
Diluted Net Income Available to Common Stockholders
121,510 141,210 178,726 290,396 293,909
Common Dividend per Share
0.55 0.55 0.60 1.10 0.90
Basic EPS
1.39 1.61 2.01 3.25 3.29
Diluted EPS
1.39 1.61 2.01 3.25 3.29
Basic Weighted Average Shares Outstanding
87,144.54 87,536.08 88,851.06 89,440.57 89,440.57
Diluted Weighted Average Shares Outstanding
87,144.54 87,536.08 88,851.06 89,440.57 89,440.57
Income Statement, Supplemental
EBIT
175,746 213,946 247,017 398,767 399,832
EBITDA
340,324 340,324 379,788 472,830 469,601
Normalized EBITDA
343,471 343,471 380,101 473,492 416,114
Normalized Income
120,245 144,654.90 180,388.12 292,477.70 256,705.03
Total Unusual Items
0 3,147 313 662 -53,487
9/30/2022 - 8/3/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: